Studies have shown that bone afferent neurons of GFRα1 and GFRα2 are mostly nonpeptidergic; therefore, GDNF and neuroturin signaling through nonpeptidergic sensory neurons may be important for bone pain in FD/MAS. This evidence concerns the gene GFRA1 and Fabry disease.